Experts Question Recent Pharma Acquisitions.
Bristol-Myers Squibb recently purchased Celgene, and Eli Lilly bought Loxo Oncology. These acquisitions probably don't indicate a shift in the types of cancer drugs companies plan to develop, but experts doubt that they will prove profitable and expect that higher drug prices will result, at least in the short term.